Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Operating Margin
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of operating margin.
The trailing-twelve-month operating margin at SurModics (NASDAQ: SRDX) is 32.12%. SurModics had $28.43 million in total cash for the latest quarter.
The trailing-twelve-month operating margin at Meridian Bioscience (NASDAQ: VIVO) is 30.48%. Meridian Bioscience's ROE for the same period is 25.63%.
The trailing-twelve-month operating margin at Trinity Biotech plc (NASDAQ: TRIB) is 19.54%. Trinity Biotech's revenue for the same period is $86.08 million.
The trailing-twelve-month operating margin at Quidel (NASDAQ: QDEL) is 10.92%. Quidel's PEG ratio is 5.12.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Diagnostic Substances Industry Operating Margin small-capTrading Ideas
